How are Anti-Inflammatory Agents Linked to Cancer?
Chronic inflammation can create a microenvironment favorable for tumor development and progression. Inflammatory cells can release cytokines, growth factors, and reactive oxygen species that promote cellular proliferation, angiogenesis, and DNA damage. By reducing inflammation, anti-inflammatory agents may help to reduce the risk of cancer development or progression. For example, studies have shown that regular use of NSAIDs like aspirin can lower the risk of colorectal cancer.
